0000930413-12-001600.txt : 20120316
0000930413-12-001600.hdr.sgml : 20120316
20120316152908
ACCESSION NUMBER: 0000930413-12-001600
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120315
FILED AS OF DATE: 20120316
DATE AS OF CHANGE: 20120316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Richard A
CENTRAL INDEX KEY: 0001490283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12957
FILM NUMBER: 12697538
MAIL ADDRESS:
STREET 1: C/O ENZON PHARMACEUITCALS, INC.
STREET 2: 685 ROUTE 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
BUSINESS PHONE: 732-980-4500
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON INC
DATE OF NAME CHANGE: 19920703
4
1
c68946_form4.xml
OWNERSHIP DOCUMENT
X0304
4
2012-03-15
0
0000727510
ENZON PHARMACEUTICALS INC
ENZN
0001490283
Young Richard A
C/O ENZON PHARMACEUTICALS, INC.
20 KINGSBRIDGE ROAD
PISCATAWAY
NJ
08854
1
0
0
0
Common Stock
2012-03-15
4
S
0
2000
6.9211
D
19562
D
Represents the sale of 2,000 shares in two separate transactions, ranging from $6.92 to $6.9212 per share, resulting in a weighted average sale price per share of $6.9211. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
/s/ Andrew Rackear, Attorney-in-Fact
2012-03-16